Drugs For Sinusitis Market

Sinusitis, also known as a sinus infection or rhinosinusitis, is inflammation of the sinuses resulting in symptoms. Common signs and symptoms include thick nasal mucus, a plugged nose, and pain in the face. Other signs and symptoms may include fever, headaches, poor sense of smell, sore throat, and cough. The cough is often worse at night. Serious complications are rare. It is defined as acute rhinosinusitis (ARS) if it lasts less than 4 weeks, and chronic rhinosinusitis (CRS) if it lasts for more than 12 weeks. Drugs for Sinusitis are common in the market, and the drugs can also be used in other disease. These drugs can not cure sinusitis, can only relieve symptoms.

Drugs For Sinusitis Market contains market size and forecasts of Drugs For Sinusitis in global, including the following market information:

Global Drugs For Sinusitis Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global Drugs For Sinusitis Market Sales, 2017-2022, 2023-2028, (K Units)

Global top five Drugs For Sinusitis companies in 2021 (%)

The global Drugs For Sinusitis market was valued at 2300.7 million in 2021 and is projected to reach US$ 2916.3 million by 2028, at a CAGR of 3.4% during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Antibiotics Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Drugs For Sinusitis include Sanofi, Bayer AG, Pfizer, AstraZeneca Plc, Novartis AG., Johnson & Johnson, Merck, Amgen and Bionorica SE, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Drugs For Sinusitis manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Drugs For Sinusitis Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Drugs For Sinusitis Market Segment Percentages, by Type, 2021 (%)

Antibiotics

Corticosteroids

Decongestants

Other

Global Drugs For Sinusitis Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Drugs For Sinusitis Market Segment Percentages, by Application, 2021 (%)

Acute Sinusitis

Chronic Sinusitis

Global Drugs For Sinusitis Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Drugs For Sinusitis Market Segment Percentages, By Region and Country, 2021 (%)

North America

US

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Nordic Countries

Benelux

Rest of Europe

Asia

China

Japan

South Korea

Southeast Asia

India

Rest of Asia

South America

Brazil

Argentina

Rest of South America

Middle East & Africa

Turkey

Israel

Saudi Arabia

UAE

Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Drugs For Sinusitis revenues in global market, 2017-2022 (Estimated), ($ millions)

Key companies Drugs For Sinusitis revenues share in global market, 2021 (%)

Key companies Drugs For Sinusitis sales in global market, 2017-2022 (Estimated), (K Units)

Key companies Drugs For Sinusitis sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

Sanofi

Bayer AG

Pfizer

AstraZeneca Plc

Novartis AG.

Johnson & Johnson

Merck

Amgen

Bionorica SE

Dr. Reddy's Laboratories

Huasun